February 09, 2016
GenomeWeb published an in-depth article about NEUMANN:
Hungary’s Neumann Diagnostics Readies HPV, Cervical Cancer Risk Test for European Market
The company’s Confidence assays are designed to detect if a woman has a high-risk HPV subtype and, if so, determine her risk of developing cervical pre-cancer or cancer.
NextGenomeWeb’s in-depth story on NEUMANN
© 2021 Neumann Diagnostics Ltd.